Home › Compare › RGNNF vs MRK

RGNNF vs MRK: Dividend Comparison 2026

RGNNF yields 357.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGNNF wins by $5043.11M in total portfolio value
10 years
RGNNF
RGNNF
● Live price
357.05%
Share price
$0.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5043.17M
Annual income
$3,251,665,029.71
Full RGNNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RGNNF vs MRK

📍 RGNNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGNNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGNNF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RGNNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGNNF
Annual income on $10K today (after 15% tax)
$30,349.01/yr
After 10yr DRIP, annual income (after tax)
$2,763,915,275.25/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RGNNF beats the other by $2,763,906,946.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGNNF + MRK for your $10,000?

RGNNF: 50%MRK: 50%
100% MRK50/50100% RGNNF
Portfolio after 10yr
$2521.61M
Annual income
$1,625,837,413.92/yr
Blended yield
64.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RGNNF
No analyst data
Altman Z
-0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGNNF buys
0
MRK buys
0
No recent congressional trades found for RGNNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGNNFMRK
Forward yield357.05% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$5043.17M ✓$56.8K
Annual income after 10y$3,251,665,029.71 ✓$9,798.13
Total dividends collected$4872.92M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RGNNF vs MRK ($10,000, DRIP)

YearRGNNF PortfolioRGNNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$46,405$35,704.72$11,206$366.19+$35.2K → RGNNF
2$204,501$154,847.45$12,650$502.35+$191.9K → RGNNF
3$856,568$637,752.95$14,407$694.19+$842.2K → RGNNF
4$3,413,056$2,496,527.84$16,585$967.82+$3.40M → RGNNF
5$12,948,780$9,296,810.40$19,342$1,363.89+$12.93M → RGNNF
6$46,818,871$32,963,675.80$22,913$1,947.19+$46.80M → RGNNF
7$161,485,607$111,389,415.47$27,662$2,823.89+$161.46M → RGNNF
8$531,854,566$359,064,965.70$34,159$4,173.35+$531.82M → RGNNF
9$1,674,303,342$1,105,218,957.19$43,337$6,308.80+$1674.26M → RGNNF
10$5,043,169,606$3,251,665,029.71$56,776$9,798.13+$5043.11M → RGNNF

RGNNF vs MRK: Complete Analysis 2026

RGNNF — Stock

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. The company explores for, develops, and sells compressed natural gas, as well as liquefied helium and natural gas. Renergen Limited was incorporated in 2014 and is based in Johannesburg, South Africa.

Full RGNNF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RGNNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGNNF vs SCHDRGNNF vs JEPIRGNNF vs ORGNNF vs KORGNNF vs MAINRGNNF vs JNJRGNNF vs ABBVRGNNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.